Joseph W. LaPlume, EVP, Corporate Strategy & Develop at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL), sold 14,036 shares at $280.75 ($4.0M) on 2021-02-25, disclosed to the SEC on 2021-02-26.
Open-market sale of $4.0M CRL by EVP, Corporate Strategy & Develop. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $280.75 | 2,012 | $565K | 14.3% |
| 2 | $281.41 | 4,334 | $1.2M | 30.9% |
| 3 | $281.41 | 4,334 | $1.2M | 30.9% |
| 4 | $282.27 | 967 | $273K | 6.9% |
| 5 | $282.27 | 967 | $273K | 6.9% |
| 6 | $283.50 | 1,422 |
| $403K |
| 10.2% |
| Total | $281.65 avg | 14,036 | $4.0M | 100% |
| Filing → |
| CRL | SELL | 2025-08-20 | $126K | — | Filing → |
| CRL | SELL | 2025-08-08 | $60K | — | Filing → |
| CRL | SELL | 2025-05-15 | $73K | — | Filing → |